Warning letter
Navajo Manufacturing Company, Inc.: warning letter of Dec 2, 2002
FDA warning letter UCM145332 · Denver District Office
Key facts
| Reference number | UCM145332 |
|---|---|
| Company | Navajo Manufacturing Company, Inc. |
| Subject | CGMP in Manufacturing, Processing, Packing or Holding/CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Dec 2, 2002 |
| Posted date | Dec 2, 2002 |
| Issuing office | Denver District Office |
| Product type | Devices |
| CFR sections cited | 211.125(a), 211.134(a), 211.198(a), 211.130, 211.182, 211.186, 211.22(a), 211.25(a), 211.122(a) |
| Country | 3 |
| Inspection city | Denver |
| Inspection ZIP | 80216-1630 |
| Inspection start date | Jul 8, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: